Close
FINDING CURES TOGETHER<sup>SM</sup>

Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

September 25-28, 2016
Sheraton New York Times Square Hotel
New York, New York
 
Conference Co-chairpersons
James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, Texas
Philip D. Greenberg, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington
Christoph Huber, Association for Cancer Immunotherapy (CIMT), Mainz, Germany
Guido Kroemer, Institut Gustave Roussy, Villejuif, France

Planning Committee Members
Wolf Fridman, Centre de Recherche des Cordeliers, Paris, France
Axel Hoos, GlaxoSmithKline, Collegeville, Pennsylvania
Elizabeth M. Jaffee, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Peter W.M. Johnson, Cancer Research UK Centre Southampton General Hospital, Southampton, United Kingdom
Cornelis J.M. Melief, Leiden University Medical Center & ISA Pharmaceuticals, Leiden, The Netherlands
Ira Mellman, Genentech, Inc., South San Francisco, California
Ellen Puré, University of Pennsylvania, Philadelphia, Pennsylvania
Catherine Sautés-Fridman, Universite Paris-Descartes, Paris, France
Drew Pardoll, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Robert D. Schreiber, Washington University School of Medicine, St. Louis, Missouri
Ozlem Tureci, Ganymed Pharmaceuticals, Mainz, Germany
E. John Wherry, University of Pennsylvania, Philadelphia, Pennsylvania
Theresa L. Whiteside, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania
Laurence Zitvogel, Institut Gustave Roussy, Villejuif, France

About the Conference
The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to present the International Cancer Immunotherapy Conference. The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.  This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates. 

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available

Visit the Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival website for more information.

#cicon16